Lilly direct-selling Zepbound at $499/mo — compare with 11 other programs

Cialis drug interactions

Cialis · tadalafil · by Eli Lilly

Reviewed by the glpzoom Editorial Team against primary clinical sources — FDA labeling, peer-reviewed trials, and specialty-society guidelines.
Content current as of June 2026; updated when guidance or availability changes.
Same critical contraindication as Viagra: nitrates can cause life-threatening hypotension. Never combine. Caution with alpha-blockers and CYP3A4 inhibitors. Daily low-dose Cialis (2.5-5mg) has the same interaction profile as as-needed dosing — same drugs to avoid, same monitoring.

Interaction lookup

Search by medication name or drug class to see clinically meaningful Cialis interactions.

  • Nitrates

    Major

    Class: nitrate

    Severe hypotension — never combine. Tadalafil's long half-life means the 24-hour rule extends to 48 hours after the last dose.

  • Alpha-blockers

    Moderate

    Class: alpha-blocker

    Hypotension risk; lower starting dose, stable alpha-blocker regimen required.

  • Ritonavir

    Major

    Class: CYP3A4 inhibitor

    Maximum 10 mg every 72 hours; significant exposure increase.

Editorial table from FDA labels + drug compendia. Not exhaustive. Discuss any concurrent medication, supplement, or condition with your prescriber before starting or stopping treatment.

Where to get Cialis

More on Cialis

People also ask

Frequently asked

What medications interact with Cialis?+

Same critical contraindication as Viagra: nitrates can cause life-threatening hypotension. Never combine. Caution with alpha-blockers and CYP3A4 inhibitors. Daily low-dose Cialis (2.5-5mg) has the same interaction profile as as-needed dosing — same drugs to avoid, same monitoring.

Can I take Cialis with metformin?+

Cialis and metformin are commonly co-prescribed without major interaction concerns. GI side effects may be additive in some patients.

Get Cialis via Himsfrom $13/mo
We may earn a commission when you click links to partners. Affiliate disclosure.